Trade YARW stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Yarrow Bioscience, Inc. (YARW) is trading at US$19.71, down 0.81% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$97.25M. Over the past 52 weeks, YARW has traded between US$16.04 and US$46.95. On Syfe you can trade YARW with $0 commission and add it to your watchlist.
| Previous close | US$19.87 |
|---|---|
| Market cap | US$97.25M |
| 52-week range | US$16.04 – US$46.95 |
| Volume | 162.19K |
| Exchange | US |
Yarrow Bioscience, Inc.
Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company is developing YB-101, a potentially first-of-its-kind antibody therapy aimed at treating Graves disease (GD) and thyroid eye disease (TED). Yarrow Bioscience was founded in October 2025 and is headquartered in New Haven, CT.
Year: 2026
Yarrow Bioscience Launches Public Offering of Common Stock
Sep 10, 8:31 PM · MT Newswires
Yarrow Bioscience, Inc. (YARW) stock is trading at US$19.71, -0.81% from the previous close of US$19.87.
The market cap for Yarrow Bioscience, Inc. (YARW) stock is approximately US$97.25M.
The 52-week high for Yarrow Bioscience, Inc. (YARW) stock is US$46.95.
The 52-week low for Yarrow Bioscience, Inc. (YARW) stock is US$16.04.
Yarrow Bioscience, Inc. (YARW) does not currently pay a dividend.
Stay on top of YARW
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
